Skip to main content
Equibles

XTX Topco Ltd

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1828301 LONDON, X0
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,405,011
+$650,345 QoQ
Shares Held
289,693
-10.2% QoQ
Ownership
0.404%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#35
of 114 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. ZNTL ranks #92 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 30,522 $19,031,687
2 ASND
Ascendis Pharma A/S
 43,289 $11,546,042
3 BBIO
BridgeBio Pharma, Inc.
 116,611 $8,685,187
4 MRNA
Moderna, Inc.
 123,281 $8,633,368
5 JAZZ
Jazz Pharmaceuticals plc
 30,496 $7,348,621
6 KYMR
Kymera Therapeutics, Inc.
 61,501 $7,052,319
7 CYTK
Cytokinetics Inc
 80,743 $6,878,496
8 PTCT
Ptc Therapeutics, Inc.
 81,923 $6,682,459

All Filings in ZNTL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,405,011 289,693
2026-03-31 $754,666 322,507
2025-12-31 $778,554 576,707
2025-09-30 $828,429 548,629
2025-06-30 $307,201 264,829
2025-03-31 $197,789 124,396
2024-12-31 $372,653 122,988
2024-09-30 $714,148 194,062
2024-06-30 $729,921 178,465
2024-03-31 $167,229 10,611
2023-09-30 $381,300 19,008
2023-03-31 $364,898 21,215
2022-09-30 $209,127 9,655